A STUDY TO ASSESS THE EFFECT OF AYURVEDIC TREATMENT IN THE BIOMARKER TNF-ALPHA IN PSORIASIS

EFFECT OF SNEHAPANA AND VIRECHANA IN THE PROINFLAMMATORY BIOMARKER TNF-Î± IN PSORIASIS - PASI

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/028867

Enrollment

Registered

2020-11-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: Shaddharanam Choornam, Mahathikthakam Ghrtam, Psorset Oil, Vellaruku Tailam: Shaddharanam Choornam 5gm at 8am and 4pm for 3days orally, Mahathikthakam Ghrtam at 6am for 7days orally, Ps

Eligibility

Inclusion criteria

Inclusion criteria: 1. External dryness 2. Itching 3. Scaling 4. Thickness 5. Erythematous patches 6. Well demarcated plaques of skin 7. Auspitz sign 8. Those who are willing to take part in the trial

Exclusion criteria

Exclusion criteria: 1. Other autoimmune diseases 2. Infectious diseases 3. Multiple joint pain 4. Chronic systemic disorders or congenital disorders 5. Under steroid therapy 6. Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
TNF-Î± value PASI SCORETimepoint: Assessment of TNF-Î± will be done on 0th day, 19th day and on 45th day PASI SCORE before and after treatment	—

Secondary

Measure	Time frame
Generalised well being of the patientTimepoint: 45days	—

Countries

India

Contacts

Public ContactDr Neethi Rajan

Government Ayurveda College Thiruvananthapuram

krishnannairck@gmail.com9447260138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026